| Authors: |
Appleton JP; Stroke Trials Unit, Mental Health & Clinical Neurosciences, University of Nottingham, South Block D Floor, Queen's Medical Centre, Nottingham, NG7 2UH, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Woodhouse LJ; Stroke Trials Unit, Mental Health & Clinical Neurosciences, University of Nottingham, South Block D Floor, Queen's Medical Centre, Nottingham, NG7 2UH, UK., Beridze M; The First University Clinic of Tblisi, State Medical University, Tbilisi, Georgia., Christensen H; Department of Neurology, University of Copenhagen, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark., Dineen RA; NIHR Nottingham Biomedical Research Centre, Nottingham, UK.; Radiological Sciences, Mental Health & Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK., England TJ; Stroke Trials Unit, Mental Health & Clinical Neurosciences, University of Nottingham, South Block D Floor, Queen's Medical Centre, Nottingham, NG7 2UH, UK., Ranta A; Department of Medicine, University of Otago, Wellington, New Zealand., Robinson TG; Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Sprigg N; Stroke Trials Unit, Mental Health & Clinical Neurosciences, University of Nottingham, South Block D Floor, Queen's Medical Centre, Nottingham, NG7 2UH, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Bath PM; Stroke Trials Unit, Mental Health & Clinical Neurosciences, University of Nottingham, South Block D Floor, Queen's Medical Centre, Nottingham, NG7 2UH, UK. Philip.bath@nottingham.ac.uk.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK. Philip.bath@nottingham.ac.uk. |
